Business Description
Scilex Holding Company is a Palo Alto-based healthcare business focused on developing and selling non-opioid treatments for both short-term and long-term pain. Its current lineup includes a lidocaine skin patch for post-shingles nerve pain, a liquid migraine treatment, and an oral solution for preventing gout flare-ups. The company is also advancing three pipeline treatments targeting sciatica, neck and back pain, and fibromyalgia, each having completed at least one clinical trial phase. Scilex works with partners in Japan and the United States to support product development and manufacturing.